Article
Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9
15 Nov 2021
Abstract excerpt
Abstract To investigate clonal hematopoiesis associated gene mutations in vitro and to unravel the direct impact on the human stem and progenitor cell (HSPC) compartment, we targeted healthy, young hematopoietic progenitor cells, derived from umbilical cord blood samples, with CRISPR/Cas9 technology. Site-specific mutations were introduced in defined regions of DNMT3A , TET2 , and ASXL1 in CD34 + progenitor cells...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
